News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Daily News Homozygous FH Diagnosis Often Comes Late, With Lackluster Care Michael O'Riordan February 10, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study Yael L. Maxwell January 03, 2022
News Daily News FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels Michael O'Riordan December 22, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Daily News Less Cancer Among HF Patients Taking Statins, Registry Shows Michael O'Riordan June 23, 2021
News Daily News First PCIs Preceded by Many Modifiable Risk Factors: Registry Data L.A. McKeown June 16, 2021
News Conference News EAS 2021 Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI Michael O'Riordan June 07, 2021
News Conference News ACC 2021 Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF Yael L. Maxwell May 16, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Daily News Inclisiran Approved in Europe for Lowering LDL Cholesterol Michael O'Riordan December 11, 2020
News Conference News EAS 2020 Just One-Third of European Patients Get to LDL Cholesterol Goals Michael O'Riordan October 13, 2020
News Daily News ‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms L.A. McKeown July 17, 2020